BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11122433)

  • 1. Gastric or intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas.
    Kabashima A; Yao T; Sugimachi K; Tsuneyoshi M
    Histopathology; 2000 Dec; 37(6):513-22. PubMed ID: 11122433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal phenotypic expression of gastric depressed adenomas and the surrounding mucosa.
    Oya M; Yao T; Nakamura T; Nakanishi K; Tsuneyoshi M
    Gastric Cancer; 2003; 6(3):179-84. PubMed ID: 14520532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions.
    Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
    Oncology; 2001; 61(3):212-20. PubMed ID: 11574777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma.
    Nakamura T; Yao T; Kabashima A; Nishiyama K; Maehara Y; Tsuneyoshi M
    Histopathology; 2005 Oct; 47(4):357-67. PubMed ID: 16178890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogenesis of intestinal and diffuse types of gastric carcinoma.
    Laurén P
    Scand J Gastroenterol Suppl; 1991; 180():160-4. PubMed ID: 2042032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas.
    Kabashima A; Yao T; Maehara Y; Tsuneyoshi M
    Gastric Cancer; 2005; 8(4):220-7. PubMed ID: 16328596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype.
    Shibata N; Watari J; Fujiya M; Tanno S; Saitoh Y; Kohgo Y
    Hum Pathol; 2003 Jan; 34(1):32-40. PubMed ID: 12605364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
    Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
    Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
    Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
    Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
    Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosa.
    Machado JC; Carneiro F; Blin N; Sobrinho-Simões M
    Eur J Cancer Prev; 1996 Jun; 5(3):169-79. PubMed ID: 8818606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic features of minute and small human gastric adenocarcinomas.
    Mori M; Enjoji M; Sugimachi K
    Arch Pathol Lab Med; 1989 Aug; 113(8):926-31. PubMed ID: 2757494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinalization of gastric signet ring cell carcinomas with progression.
    Yamachika T; Inada K; Fujimitsu Y; Nakamura S; Yamamura Y; Kitou T; Itzkowitz SH; Werther JL; Miki K; Tatematsu M
    Virchows Arch; 1997 Aug; 431(2):103-10. PubMed ID: 9293891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between biologic behavior and phenotypic expression in intramucosal gastric carcinomas.
    Kabashima A; Yao T; Sugimachi K; Tsuneyoshi M
    Hum Pathol; 2002 Jan; 33(1):80-6. PubMed ID: 11823976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent expression of intestinal phenotype in signet ring cell carcinomas of the human stomach.
    Bamba M; Sugihara H; Kushima R; Okada K; Tsukashita S; Horinouchi M; Hattori T
    Virchows Arch; 2001 Jan; 438(1):49-56. PubMed ID: 11213835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
    Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
    Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between expression of sialosyl-Tn antigen and intestinalization of gastric carcinomas.
    Kushima R; Jancic S; Hattori T
    Int J Cancer; 1993 Dec; 55(6):904-8. PubMed ID: 8253526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Paneth cells in pyloric glands associated with gastric and intestinal mixed-type intestinal metaplasia of the human stomach.
    Inada K; Tanaka H; Nakanishi H; Tsukamoto T; Ikehara Y; Tatematsu K; Nakamura S; Porter EM; Tatematsu M
    Virchows Arch; 2001 Jul; 439(1):14-20. PubMed ID: 11499835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.
    Morohara K; Tajima Y; Nakao K; Nishino N; Aoki S; Kato M; Sakamoto M; Yamazaki K; Kaetsu T; Suzuki S; Tsunoda A; Tachikawa T; Kusano M
    J Cancer Res Clin Oncol; 2006 Jun; 132(6):363-75. PubMed ID: 16447040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil.
    Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):683-90. PubMed ID: 14576935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.